BioAdaptives Company Insiders
| BDPT Stock | USD 0.04 0.01 19.77% |
BioAdaptives employs about 3 people. The company is managed by 3 executives with a total tenure of roughly 7 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Breaking down BioAdaptives' management performance can provide insight into the firm performance.
| Robert Ellis Insider CFO Pres |
| Charles Townsend Insider COO Director |
BioAdaptives |
BioAdaptives Management Team Effectiveness
The company has return on total asset (ROA) of (3.4344) % which means that it has lost $3.4344 on every $100 spent on assets. This is way below average. BioAdaptives' management efficiency ratios could be used to measure how well BioAdaptives manages its routine affairs as well as how well it operates its assets and liabilities.BioAdaptives Workforce Comparison
BioAdaptives is rated below average in number of employees category among its peers. The total workforce of Packaged Foods industry is currently estimated at about 41.0. BioAdaptives holds roughly 3.0 in number of employees claiming about 7% of equities listed under Packaged Foods industry.
BioAdaptives Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. BioAdaptives Price Series Summation is a cross summation of BioAdaptives price series and its benchmark/peer.
BioAdaptives Notable Stakeholders
A BioAdaptives stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as BioAdaptives often face trade-offs trying to please all of them. BioAdaptives' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting BioAdaptives' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Robert Ellis | CFO Pres | Profile | |
| Charles Townsend | COO Director | Profile | |
| MD Jacobs | CEO Chairman | Profile |
About BioAdaptives Management Performance
The success or failure of an entity such as BioAdaptives often depends on how effective the management is. BioAdaptives management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of BioAdaptives management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the BioAdaptives management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
BioAdaptives, Inc. markets and distributes natural plant and algal-based products for humans and animals. BioAdaptives, Inc. was incorporated in 2013 and is based in Las Vegas, Nevada. Bioadaptives operates under Packaged Foods classification in the United States and is traded on OTC Exchange. It employs 3 people.
Please note, the imprecision that can be found in BioAdaptives' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of BioAdaptives. Check BioAdaptives' Beneish M Score to see the likelihood of BioAdaptives' management manipulating its earnings.
BioAdaptives Workforce Analysis
Traditionally, organizations such as BioAdaptives use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare BioAdaptives within its industry.BioAdaptives Manpower Efficiency
Return on BioAdaptives Manpower
| Revenue Per Employee | 6.6K | |
| Revenue Per Executive | 6.6K | |
| Net Loss Per Employee | 350K | |
| Net Loss Per Executive | 350K |
Additional Tools for BioAdaptives Pink Sheet Analysis
When running BioAdaptives' price analysis, check to measure BioAdaptives' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAdaptives is operating at the current time. Most of BioAdaptives' value examination focuses on studying past and present price action to predict the probability of BioAdaptives' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAdaptives' price. Additionally, you may evaluate how the addition of BioAdaptives to your portfolios can decrease your overall portfolio volatility.